Skip to main content
REVB logo

REVB · Revelation Biosciences, Inc. · Held by Funds

Track REVB — free
$3.71 +0.02 (+0.54%)
Market Cap
$2.52M
Shares
683,442
Volume · Nov 20 1858 Avg daily vol (23 sessions) 20.32K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of REVB by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.89% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.89% 6,053
Index ETFs 0.00% 0
Active ETFs 0.00% 0
Active funds 0.00% 7
Unclassified 0.00% 0
All registered funds 0.89% 6,060
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding REVB

2 fund positions
Fund Balance Value % of Fund Open
Showing 1–2 of 2 positions
Key facts CIK 1810560 CUSIP 76135L887 13F (30d) 16 filings 14 filers Visit website Investor relations